Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.39 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.39 |
| ▸ | NR1H2 | P55055 | 2/20 | 0.32 |
| ▸ | NR1H3 | Q13133 | 2/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | ACHE | P22303 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29392326 | 0.97 | ESR1 (0.38) | ESR1ESR2NR1H2NR1H3CA4 | |
| SCHEMBL5552262 | 0.93 | ESR1 (0.35) | ESR1ESR2 | |
| SCHEMBL3154426 | 0.91 | ESR1 (0.34) | ESR1ESR2 | |
| SCHEMBL8763804 | 0.91 | ESR1 (0.34) | ESR1ESR2 | |
| SCHEMBL18094247 | 0.87 | ESR1 (0.32) | ESR1ESR2CA4 | |
| SCHEMBL2048191 | 0.84 | ESR1 (0.39) | ESR1ESR2NR1H2NR1H3CA4 | |
| SCHEMBL13621322 | 0.84 | ESR1 (0.39) | ESR1ESR2NR1H2NR1H3CA4 | |
| SCHEMBL15949975 | 0.84 | ESR1 (0.31) | ESR1ESR2 | |
| SCHEMBL15950038 | 0.84 | ESR1 (0.31) | ESR1ESR2 | |
| SCHEMBL15950037 | 0.84 | ESR1 (0.31) | ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3458499-B1 | FLAME RETARDANT RESIN COMPOSITION | MOMENTIVE PERFORMANCE MAT INC (US) | 2026-03-25 | — | — | EP | disclosed |
| US-20240247107-A1 | CROSS-LINKABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | WACKER CHEMIE AG (DE) | 2024-07-25 | — | — | US | disclosed |
| EP-4347702-A1 | CROSS-LINKABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | Wacker Chemie AG (DE) | 2024-04-10 | — | — | EP | disclosed |
| WO-2022253413-A1 | CROSS-LINKABLE ORGANOSILOXANE-MODIFIED REACTION RESINS | WACKER CHEMIE AG (DE) | 2022-12-08 | — | — | WO | disclosed |
| CN-109642029-B | Flame-retardant resin composition | 莫门蒂夫性能材料股份有限公司 | 2022-02-18 | — | — | CN | disclosed |
| US-10266648-B2 | Flame retardant resin composition | MOMENTIVE PERFORMANCE MATERIALS INC. (US) | 2019-04-23 | — | — | US | disclosed |
| US-20170369644-A1 | FLAME RETARDANT RESIN COMPOSITION | MOMENTIVE PERFORMANCE MATERIALS INC. | 2017-12-28 | — | — | US | disclosed |
| US-20170369644-A1 | FLAME RETARDANT RESIN COMPOSITION | MOMENTIVE PERFORMANCE MATERIALS INC. | 2017-12-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10266648-B2 | Flame retardant resin composition | RER1, GAR1, AFF1 | ESR1 1082/4885ESR2 836/4885NR1H2 425/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.